Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
03/2003
03/26/2003EP1295867A1 Biphenyl compound
03/26/2003EP1294823A1 Double-spiro organic compounds and electroluminescent devices
03/26/2003EP1294700A2 Benzhydryl derivatives
03/26/2003EP1294684A2 THROMBIN OR FACTOR Xa INHIBITORS
03/26/2003EP1294679A1 Beta-amino acid nitrile derivatives
03/26/2003CN1405156A N-hydroxy amidino compound and its preparation method
03/26/2003CN1103770C Quino xaline diones
03/25/2003US6537993 Compounds for enhancing chemotherapy
03/20/2003WO2003023504A1 Flexible electrochromic devices
03/20/2003WO2003022820A1 Heteroaromatic substituted cyclopropane as corticotropin releasing hormone
03/20/2003WO2003022785A2 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003US20030055247 Thiazolyl(pyridyl)ethyne compounds
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055071 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/20/2003CA2456614A1 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
03/19/2003EP1292580A1 Pyrazine and imidazopyrazine derivatives as antioxidants
03/19/2003EP1292579A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
03/19/2003EP1042314B1 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
03/19/2003EP0956141B1 Amine heat stable salt neutralization having reduced solids
03/19/2003CN1404471A Substituted piperazine compounds
03/19/2003CN1403448A Process for producing 2-(4-alkyl-1-piperazyl)-benzaldehyde and-benzal compound
03/19/2003CN1103333C Selective thrombin inhibitors
03/18/2003US6534535 Inhibitors of factor Xa
03/18/2003US6534509 Derivatives are useful as anti-inflammatory agents. This invention is also directed to pharmacetutical compostions for inflammation
03/18/2003US6534447 Herbicidal pyridine compounds
03/18/2003CA2217351C Carbonyl-piperazinyl and piperidinyl compounds which inhibit farnesyl protein transferase
03/13/2003WO2003020688A1 Selective protein tyrosine phosphatase inhibitors
03/13/2003WO2003020029A1 Arylamines as inhibitors of chemokine binding to us28
03/13/2003WO2003004472A8 Arylamines for the treatment of conditions associated with gsk-3
03/13/2003US20030050475 Contacting a 5 or 6-methyl quinoxaline with a halogenating agent in the presence of radical initiator in solvent (mono,di,tri fluoro or chlorobenzenes or a,trichloro or fluorotoluene to form 5 or 6- halomethylquinoxaline
03/12/2003EP1289999A1 Antitumoral analogs of et-743
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1200824A4 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
03/12/2003EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1401639A Process for synthesis of azacyclic compounds
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531476 Piperazine derivatives inhibiting human immunodeficiency virus replication
03/11/2003US6531241 Anions of equal number to cations to maintain charge neutrality, are disclosed. These spacer groups may be organic or inorganic in origin and may vary in length. The spacer groups may be saturated, containing single bonds, or may have
03/06/2003WO2003019145A2 Non-fluorescent quencher compounds and biomolecular assays
03/06/2003WO2003018549A2 Bicyclic compounds as inhibitors of chemokine binding to us28
03/06/2003WO2003018515A2 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
03/06/2003WO2003017939A2 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
03/06/2003WO2003017765A1 Treatment for cystic fibrosis
03/06/2003WO2002083662A3 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds
03/06/2003WO2002046160A3 Process for making a thrombin inhibitor
03/06/2003US20030045524 Particularly quinoxaline, (2-imidozolin-2-ylamino) quinoxaline, or 5-bromo-6-(2-imidozolin-2-ylamino) quinoxaline and linolenic acid, which may be complexed with the quinoxaline agonist
03/06/2003CA2449515A1 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
03/05/2003EP1288208A1 Process for the preparation of 2-(4-Alkyl-1-Piperazinyl)-Benzaldehyde and -Benzylidenyl compounds by Nucleophilc Aromatic Substitution of 2-Fluorobenzaldehyde with 4-Alkyl-1-Piperazine in Water as Solvent
03/05/2003EP1287004A1 Synthetic process for the manufacture of an ecteinascidin compound
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286973A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
03/05/2003EP1286968A2 Substituted iminoazines
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286955A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003CN1400970A Substituted arylpyrazines
03/05/2003CN1400969A Fused imidazolium derivatives
03/04/2003US6528687 Hydrogenation of an imine in the presence of a base and, a ruthenium complex of a chiral diphosphine and diamine catalyst
03/04/2003US6528526 Inhibition of cell proliferation and/or cell matrix production and/or cell movement (chemotaxis) and/or T cell activation and proliferation
03/04/2003US6528510 HIV protease inhibitors
02/2003
02/28/2003CA2399970A1 Process for the preparation of 2-(4-alkyl-1-piperazinyl)-benzaldehyde and -benzylidenyl compounds
02/27/2003WO2003016274A2 2-substituted piperidines that are ligands for monoamine receptors and transporters
02/27/2003WO2003016267A1 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
02/27/2003WO2003015785A1 2h-phthalazin-1-ones and methods for use thereof
02/27/2003WO2003015784A1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
02/27/2003WO2003015774A1 Compounds effecting glucokinase
02/27/2003WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes
02/27/2003WO2002083064A3 A method of treating cancer
02/27/2003US20030040518 For therapy of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons degeneration of lesioned and damaged neurons
02/27/2003CA2456985A1 2h-phthalazin-1-ones and methods for use thereof
02/26/2003EP1284966A2 Process for the synthesis of amine ethers from secondary amino oxides
02/26/2003EP0708763B1 Process for making hiv protease inhibitors
02/26/2003CN1398856A Fluidized bed catalyst for preparing 2-cyano pyrazine
02/26/2003CN1398855A Ammoxidation process of preparing 2-cyano pyrazine
02/25/2003US6525072 Prevention and treatment of cellular disorders such as cancer
02/25/2003US6525054 Cyanoiminoquinoxaline derivatives
02/25/2003US6525048 Aminomethylphenoxymethyl/benzisoxazole substituted azabicyclic compounds; depression, generalized anxiety disorder, obesity, migraine; 2-(5-Fluoro-benzo(d)isoxazol-3-y)-7-(3-morpholin-4-ylmethylphenoxymethyl) -octahydro-pyrido(1,2-a)pyrazine;
02/25/2003US6525025 Controlling apoptosis; cardiovascular disorders; central nervous system disorders
02/25/2003US6525020 For drug delivery
02/25/2003US6524347 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
02/20/2003WO2003013571A1 Peptidomimetics of biologically active metallopeptides
02/20/2003WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof
02/20/2003WO2002024635A3 Aminoalcohol derivatives
02/20/2003CA2462200A1 Peptidomimetics of biologically active metallopeptides
02/19/2003EP1284262A1 Process for the preparation of cis-2,6-dimethylpiperazine
02/19/2003CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives
02/19/2003CN1397557A NOvel octahydro-2H-pyridino-[1,2-a] pyrazine compound, its prepn. process and medicinal compound contg. them
02/19/2003CN1101812C Acorus calamus extracts in Acorus gramineus and their use
02/18/2003US6521755 Process for preparing 10,11-methanobenzosuberane derivatives
02/18/2003US6521666 Inhibitors of α4 mediated cell adhesion
02/18/2003US6521622 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
02/14/2003WO2002018326A1 Novel propenohydroxamic acid derivatives
02/14/2003CA2423733A1 Novel propenohydroxamic acid derivatives
02/13/2003WO2002076988A3 Tert. alkylphenoxy substituted polycyclic compounds
02/13/2003US20030032635 Heterocyclic esters and amides